This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Formed in 2007 by the merger of the Chicago Mercantile Exchange (CME) and the Chicago Board of Trade (CBOT), CME Group is the largest futures exchange in the world in terms of trading volume as well as notional value traded. The Chicago Mercantile Exchange was originally formed as a non-profit organization in 1898, but was converted to a for-profit company in 2000. It became the first publicly traded financial exchange in the U.S. in Dec 2002. CBOT, established in 1848, is a leading futures and options exchange. In Apr 2005, CBOT converted into a for-profit stock-based holding company and for-profit membership exchange subsidiary.
Should You Invest in the iShares U.S. BrokerDealers & Securities Exchanges ETF (IAI)?
by Zacks Equity Research
Sector ETF report for IAI
CME Group (CME), IHS Markit to Combine Post-Trade Services
by Zacks Equity Research
CME Group (CME) and IHS Markit combine their post-trade services to boost the OTC markets.
Intercontinental Exchange (ICE) Reports Soft December Volumes
by Zacks Equity Research
Intercontinental Exchange (ICE) December volumes reflect lower Commodities and Financial average daily volumes.
Cboe Global (CBOE) Posts Solid December Volumes, Guides Q4 RPC
by Zacks Equity Research
Cboe Global's (CBOE) increase in December volumes is attributable to solid performance in Options.
CME Group (CME) to Launch Electricity & LNG Futures Contracts
by Zacks Equity Research
CME Group (CME) to boost the robust suite of futures and options with the launch of Ether Futures.
MarketAxess' (MKTX) December Trading Suggests Decent Volumes
by Zacks Equity Research
MarketAxess (MKTX) reports favorable business volumes for December, reflecting higher trading across major categories, such as U.S high-grade bonds and other credit bonds.
CME Group (CME) Reports Lower December Volumes, Stock Down
by Zacks Equity Research
CME Group's (CME) average daily volume of 14.2 million contracts per day represents a decline of 8% year over year, attributable to lower volumes in four of the six product lines.
4 Financial Stocks That Could Gain Big This Year
by Swayta Shah
The Finance sector is likely to witness a turnaround after a dismal performance in 2020. Let's check out JPMorgan (JPM), CME Group (CME), Hartford Financial (HIG) & SEI Investments (SEIC) that are likely to rebound in 2021.
Does "Quadruple Witching" Create Options Trading Opportunity?
by David Borun
The inclusion of Tesla could mean big volatility during the biggest derivative expiration of 2020.
CME Group (CME) to Launch Ether Futures to Boost Crypto Trading
by Zacks Equity Research
CME Group (CME) to enhance the crypto derivatives offering with the launch of Ether Futures.
Cboe Global (CBOE) November Volume Increases Year Over Year
by Zacks Equity Research
Cboe Global's (CBOE) Options, U.S. Equities, European Equities and global forex volumes reflect year-over-year increases in November, offset by lower Futures.
Top Stock Reports for NextEra Energy, Caterpillar & Micron Technology
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including NextEra Energy, Inc. (NEE), Caterpillar Inc. (CAT) and Micron Technology, Inc. (MU).
What Makes MarketAxess (MKTX) an Attractive Bet to Investors?
by Zacks Equity Research
MarketAxess (MKTX) holds promises on the back of upward estimate revision, new product suite, acquisition announcements as well as organic growth.
Intercontinental Exchange (ICE) November ADV Improves Y/Y
by Zacks Equity Research
Intercontinental Exchange's (ICE) November volumes reflect higher Financial ADV, Commodities ADV and Energy volume, partially offset by lower Agriculture and Metals ADV.
MarketAxess' (MKTX) November Trading Suggests Strong Business
by Sapna Bagaria
MarketAxess (MKTX) posts solid numbers for November business volume, reflecting higher trading across major categories, such as U.S. high-grade bonds and other credit bonds.
Nasdaq's (NDAQ) November Volumes Increase Year Over Year
by Zacks Equity Research
Nasdaq's (NDAQ) November volumes reflect higher volumes of U.S. equity, Nasdaq's U.S. matched equity and European equity but lower European options and futures.
CME Group's (CME) November ADV Rises at Three Product Lines
by Zacks Equity Research
CME Group's (CME) average daily volume of 19.3 million contracts per day in November 2020 rises 6% year over year.
Let's Take Another Look at Commodity Options
by David Borun
With demand concerns in Energy and a "flight to safety" in Gold, it's worth considering non-equity derivatives again.
Cboe Global's (CBOE) Q3 Earnings Top, Expense View Slashed
by Zacks Equity Research
Cboe Global's (CBOE) Q3 results reflect sustained robust engagement among retail customers offset by lower trading among institutional investors.
New Strong Sell Stocks for October 30th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Intercontinental Exchange (ICE) Q3 Earnings & Revenues Beat
by Zacks Equity Research
Intercontinental Exchange (ICE) Q3 results reflect continued revenue growth driven by strong Trading and Clearing as well as Data and Listings.
CME Group (CME) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
CME Group (CME) Q3 results reflect lower clearing and transaction fees and decrease in average daily volume in three out of the six products lines.
CME Group (CME) Q3 Earnings and Revenues Lag Estimates
by Zacks Equity Research
CME (CME) delivered earnings and revenue surprises of -2.13% and -1.04%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
CME Group (CME) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
CME Group's (CME) third-quarter performance is likely to have benefited from clearing and transaction fees, market data and information services revenues and derivative product lines.
Earnings Preview: CME Group (CME) Q3 Earnings Expected to Decline
by Zacks Equity Research
CME (CME) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.